Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 179
Selected: 0
NCT IDTitle
NCT04206917MultiPulse Therapy (MPT) for AF
NCT04396340First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b
NCT07000110Anifrolumab Malignancy and Serious Infections Study
NCT06938854Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries
NCT04907968Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
NCT05633407Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
NCT03970837Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
NCT06498128Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
NCT03615924Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
NCT05508750Growth and Safety Clinical Trial on a New Infant Formula
NCT03627715Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
NCT05637515Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
NCT04625725Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
NCT05599334A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
NCT06797258FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
NCT04333147Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
NCT03976518Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)
NCT05761444Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
NCT06716801Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
NCT03254446Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT07517445Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
NCT05843916Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease
NCT04125290US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)
NCT03628235HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States
NCT03937479Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
NCT04188574A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
NCT04134728Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors
NCT03566082Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe
NCT05035680Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
NCT02104817Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
NCT04293172Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
NCT06549946Ixovex-1 Single Agent and Combination Therapy
NCT05776472A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT05016024Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
NCT05970263IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US
NCT05731908A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems
NCT05872035Smartphone Enabled Hearing Study
NCT04324437eRAPID: Online Symptom Reporting in Lung Cancer
NCT03544281To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT04542057A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT07891728A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute Pharyngitis
NCT04027439Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler
NCT04167137Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants
NCT07525427Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
NCT04072835Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT04720378Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
NCT03649152Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
NCT07603193Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream
NCT04818801Safety, Reactogenicity and Immunogenicity Study of ReCOV
NCT04718103A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype